Last reviewed · How we verify

NCT03827538: EVELHYN

Endobronchial Valves Positioning Effects On Diaphragm Function In Patients With Lung Hyperinflation

Status unknown Last updated 10 May 2023
What this trial tests

trial in Diaphragm in 30 participants. Status unknown.

Timeline
1 October 2019
Primary endpoint
31 December 2023
31 December 2024

Quick facts

Lead sponsorUniversity of Modena and Reggio Emilia
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 October 2019
Primary completion31 December 2023
Estimated completion31 December 2024
Sites1 location across Italy

Conditions studied

Sponsor

University of Modena and Reggio Emilia

Who can join

18 and older, any sex, with Diaphragm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective study aims at evaluating diaphragmatic function before and after endobronchial valves positioning in a COPD patients with lung hyperinflation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diaphragm

Currently open trials in the same condition.

Other University of Modena and Reggio Emilia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03827538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing